Real-world effectiveness of ledipasvir/sofosbuvir 8 weeks chronic hepatitis C treatment

被引：0
|
作者：
Buggisch, Peter [1 ]
Wursthorn, Karsten [1 ]
Stoehr, Albrecht [1 ]
Gauthier, Aline [2 ]
Atanasov, Petar K. [2 ]
Petersen, Joerg [1 ]
机构：
[1] IFI Inst Interdisziplinare Med, Asklepios Klin, Hamburg, Germany
[2] Amaris Consulting, London, England
来源：
HEPATOLOGY | 2015年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1205
引用
收藏
页码：806A / 806A
页数：1
相关论文
共 50 条
  • [1] REAL-WORLD EFFECTIVENESS OF LEDIPASVIR/SOFOSBUVIR 8 WEEKS CHRONIC HEPATITIS C TREATMENT
    Buggisch, P.
    Petersen, J.
    Wursthorn, K.
    Atanasov, P.
    Gauthier, A.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S280 - S280
  • [2] REAL-WORLD EFFECTIVENESS OF LEDIPASVIR/SOFOSBUVIR 8 WEEKS CHRONIC HEPATITIS C TREATMENT
    Buggisch, P.
    Wursthorn, K.
    Stoehr, A.
    Gauthier, A.
    Atanasov, P. K.
    Petersen, J.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S811 - S811
  • [3] Real-World Effectiveness of Ledipasvir/Sofosbuvir 8 Weeks Chronic Hepatitis C Treatment
    Buggisch, Peter
    Wursthorn, Karsten
    Gauthier, Aline
    Atanasov, Petar
    Petersen, Joerg
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S869 - S869
  • [4] Real-world effectiveness of ledipasvir/sofosbuvir 8 weeks chronic hepatitis C treatment
    Buggisch, P.
    Wursthorn, K.
    Gauthier, A.
    Atanasov, P.
    Petersen, J.
    JOURNAL OF VIRAL HEPATITIS, 2015, 22 : 24 - 25
  • [5] Real-world effectiveness of Ledipasvir/Sofosbuvir 8 weeks chronic hepatitis C treatment
    Buggisch, P.
    Petersen, J.
    Wursthorn, K.
    Gauthier, A.
    Atanasov, P.
    JOURNAL OF VIRAL HEPATITIS, 2015, 22 : 95 - 96
  • [6] Real-world effectiveness of 8-week treatment with ledipasvir/sofosbuvir in chronic hepatitis C
    Buggisch, Peter
    Vermehren, Johannes
    Mauss, Stefan
    Guenther, Rainer
    Schott, Eckart
    Pathil, Anita
    Boeker, Klaus
    Zimmermann, Tim
    Teuber, Gerlinde
    Vornkahl, Heike-Pfeiffer
    Simon, Karl-Georg
    Niederau, Claus
    Wedemeyer, Heiner
    Zeuzem, Stefan
    JOURNAL OF HEPATOLOGY, 2018, 68 (04) : 663 - 671
  • [7] Real-world effectiveness and cost per SVR of ledipasvir/sofosbuvir chronic hepatitis C treatment
    Buggisch, Peter
    Wursthorn, Karsten
    Stoehr, Albrecht
    Gauthier, Aline
    Atanasov, Petar K.
    Petersen, Joerg
    HEPATOLOGY, 2015, 62 : 791A - 791A
  • [8] Effectiveness of ledipasvir/sofosbuvir in real-world patients with chronic hepatitis C: a collaborative treatment approach
    Johnson, Steven W.
    Ammirati, Shelby R.
    Hartis, Charles E.
    Weber, Stephen F.
    Morgan, Michael R.
    Darnell, Timothy A.
    Silwal, Adwait
    Schmidlin, Holly N.
    Priest, David H.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 49 (06) : 778 - 781
  • [9] High efficacy of 8 weeks of ledipasvir/sofosbuvir in real-world treatment
    Tang, L.
    Parker, A.
    Flores, Y.
    Dellario, M.
    Dickson, C.
    Amoroso, A.
    Kottilil, S.
    Wilson, E.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S308 - S309
  • [10] REAL-WORLD EFFECTIVENESS AND COST PER SUSTAINED VIRAL RESPONSE OF LEDIPASVIR/SOFOSBUVIR CHRONIC HEPATITIS C TREATMENT
    Buggisch, P.
    Wursthorn, K.
    Stoehr, A.
    Gauthier, A.
    Atanasov, P. K.
    Petersen, J.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S809 - S810
12345